Concepedia

Haris Jamil

HJ

18

Publications

1.8K

Citations

17

H-Index

1991

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of California, San Francisco

Bristol-Myers Squibb (Sweden)

University of Alberta

Haris Jamil is an author at Bristol-Myers Squibb (United States) specializing in biochemistry, medicine, and natural sciences.

Top concepts

BiochemistryMedicinePharmacologyNatural SciencesDrug DiscoveryAtherosclerosisHealthChemical BiologyDrug DevelopmentMedicinal Chemistry

Publications per year

1991–2009

18

Publications

18

An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits

John R. Wetterau, Richard E. Gregg, Thomas Harrity et al. · Science · 1998 · 268 citations

Hyperlipidemia, Whhl Rabbits, Metabolic Syndrome +17

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia

Jun-shan Liang, Oliver Distler, David A. Cooper et al. · Nature Medicine · 2001 · 263 citations

Protease Inhibitor-induced Hyperlipidemia, Biochemistry, Medicine +12

The Triple Threat to Nascent Apolipoprotein B

Edward A. Fisher, Meihui Pan, Xiaoli Chen et al. · Journal of Biological Chemistry · 2001 · 187 citations · Full text

Inhibition of the Microsomal Triglyceride Transfer Protein Blocks the First Step of Apolipoprotein B Lipoprotein Assembly but Not the Addition of Bulk Core Lipids in the Second Step

David A. Gordon, Haris Jamil, Richard E. Gregg et al. · Journal of Biological Chemistry · 1996 · 166 citations · Full text

Microsomal Triglyceride Transfer Protein

Haris Jamil, John K. Dickson, Ching-Hsuen Chu et al. · Journal of Biological Chemistry · 1995 · 159 citations · Full text

Rows per page

1–5 of 18